Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
Sihuan Pharmaceutical Holdings Group Ltd のCEOは誰ですか？
Dr. Weicheng Guo は Sihuan Pharmaceutical Holdings Group Ltd の Executive Deputy Chairman of the Board で、2006 から在籍しています。
SHPHY の株価パフォーマンスは？
SHPHY の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Sihuan Pharmaceutical Holdings Group Ltd の主な事業テーマや業界は？
Sihuan Pharmaceutical Holdings Group Ltd は Pharmaceuticals 業界、セクターは Health Care に属しています。
Sihuan Pharmaceutical Holdings Group Ltd の時価総額はいくらですか？
Sihuan Pharmaceutical Holdings Group Ltd の現在の時価総額は $0 です。
Sihuan Pharmaceutical Holdings Group Ltd は、買い、売り、ホールドのどれですか？
